Results 61 to 70 of about 5,629 (238)

Pancreatic neuroendocrine tumors in children and adolescents—Data from the German MET studies (1997–2023)

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 8, August 2025.
Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges   +12 more
wiley   +1 more source

Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract a [PDF]

open access: yes, 2004
Endocrine tumours of the gastrointestinal tract and pancreas may present at different disease stages with either hormonal or hormone-related symptoms/syndromes, or without hormonal symptoms. They may occur either sporadically or as part
Eijck, C.H.J. (Casper) van   +3 more
core  

The management of neuroendocrine tumours: A nutritional viewpoint [PDF]

open access: yes, 2017
Nutritional status in patients with neuroendocrine tumours (NETs), especially of gastroenteropancreatic origin, can be deeply affected by excessive production of gastrointestinal hormones, peptides, and amines, which can lead to malabsorption, diarrhoea,
Annamaria Colao   +7 more
core   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

open access: yesCancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis   +18 more
wiley   +1 more source

[The role of endoscopy in gastroenteropancreatic neuroendocrine tumors]. [PDF]

open access: yes, 2010
[The role of endoscopy in gastroenteropancreatic neuroendocrine tumors]. [Article in Italian] Magno L, Sivero L, Napolitano V, Ruggiero S, Fontanarosa G, Massa S.
Fontanarosa G   +5 more
core  

What is the quality of smoking cessation advice in guidelines of tobacco-related diseases? [PDF]

open access: yes, 2015
Smoking is a major risk factor for a range of diseases, and quitting smoking provides considerable benefits to health. It therefore follows that clinical guidelines on disease management, particularly for diseases caused by smoking, should include ...
Agrawal, Sanjay   +5 more
core   +1 more source

Quantitative Characterization of Duodenal Gastrinoma Autofluorescence using Multi-photon Microscopy [PDF]

open access: gold, 2022
Thomas G. Knapp   +3 more
openalex   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

De novo Gastrinoma: A Case Report

open access: yesGE: Portuguese Journal of Gastroenterology, 2019
Gastrinomas are neuroendocrine tumors characterized by gastrin overexpression – 80% are sporadic and 20% are associated with multiple endocrine neoplasia type 1.
Arsénio Barbosa   +4 more
doaj   +1 more source

Primary Nodal Gastrinomas

open access: yesArchives of Pathology & Laboratory Medicine, 2000
Abstract Background.—The term primary lymph node gastrinoma was first used to describe a group of patients with gastrin-producing tumors present in lymph nodes located in a well-defined anatomic region. The patients had no known primary tumors in the pancreas or gastrointestinal tract and had disease-free survival for up to 18 years. The
M E, Herrmann   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy